| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A designer biomimetic vector for breast cancer gene therapy
|
McCarthy, H.O.
|
|
2010
|
|
23-24 |
p. 1096-
1 p.
|
artikel
|
| 2 |
A dual uptake mechanism for the peptide Tat–LK15
|
Alkotaji, Myasar
|
|
2010
|
|
23-24 |
p. 1095-
1 p.
|
artikel
|
| 3 |
Advances in the development of Rho-associated protein kinase (ROCK) inhibitors
|
Pan, Peichen
|
|
2013
|
|
23-24 |
p. 1323-1333
11 p.
|
artikel
|
| 4 |
Alkylglyceryl chitosan nanoparticles for drug delivery across the blood–brain barrier
|
Molnár, Éva
|
|
2010
|
|
23-24 |
p. 1107-
1 p.
|
artikel
|
| 5 |
Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease
|
Melancon, Bruce J.
|
|
2013
|
|
23-24 |
p. 1185-1199
15 p.
|
artikel
|
| 6 |
Amphipathic CPPs upregulate Ca in cells’ cytosol and induce lysosomal exocytosis
|
Lorents, A.
|
|
2010
|
|
23-24 |
p. 1092-
1 p.
|
artikel
|
| 7 |
Andy Southan talks about ion channel research services at BioFocus
|
Carney, Steve
|
|
2005
|
|
23-24 |
p. 1585-1587
3 p.
|
artikel
|
| 8 |
Aneuploidy and adult neurogenesis in Alzheimer's disease: therapeutic strategies
|
Taupin, Philippe
|
|
2010
|
|
23-24 |
p. 983-984
2 p.
|
artikel
|
| 9 |
Anglo-Saxon pharmacopoeia revisited: a potential treasure in drug discovery
|
Watkins, Frances
|
|
2011
|
|
23-24 |
p. 1069-1075
7 p.
|
artikel
|
| 10 |
A novel 3D model for the study of functionalised-nanoparticle penetration into human tissue
|
Child, H.
|
|
2010
|
|
23-24 |
p. 1086-1087
2 p.
|
artikel
|
| 11 |
An overview of automated systems relevant in pharmaceutical salt screening
|
Kumar, Lokesh
|
|
2007
|
|
23-24 |
p. 1046-1053
8 p.
|
artikel
|
| 12 |
Antibody targeting of lipid nanocapsules for directed drug delivery: physico-chemical characterization and in vitro study
|
Sánchez-Moreno, P.
|
|
2010
|
|
23-24 |
p. 1105-
1 p.
|
artikel
|
| 13 |
Antibody targeting of polymeric nanoparticles for cancer therapy
|
Scott, Christopher J.
|
|
2010
|
|
23-24 |
p. 1087-
1 p.
|
artikel
|
| 14 |
Anticancer drug discovery in the future: an evolutionary perspective
|
Ma, Xianghui
|
|
2009
|
|
23-24 |
p. 1136-1142
7 p.
|
artikel
|
| 15 |
Antimalarial therapies
|
Trafford, Hugh
|
|
2005
|
|
23-24 |
p. 1588-1590
3 p.
|
artikel
|
| 16 |
Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer
|
Bertolini, Francesco
|
|
2011
|
|
23-24 |
p. 1052-1060
9 p.
|
artikel
|
| 17 |
Applications of Connectivity Map in drug discovery and development
|
Qu, Xiaoyan A.
|
|
2012
|
|
23-24 |
p. 1289-1298
10 p.
|
artikel
|
| 18 |
A practical drug discovery project at the undergraduate level
|
Jonathan Fray, M.
|
|
2013
|
|
23-24 |
p. 1158-1172
15 p.
|
artikel
|
| 19 |
A receptor-mediated gene delivery system using CXCR4 ligand-conjugated cross-linking peptides
|
Egorova, A.A.
|
|
2010
|
|
23-24 |
p. 1105-
1 p.
|
artikel
|
| 20 |
A Sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond
|
Abad-Zapatero, Cele
|
|
2007
|
|
23-24 |
p. 995-997
3 p.
|
artikel
|
| 21 |
A study of the interaction of novel, coated microparticles with alveolar macrophages and their application in tuberculosis treatment via inhalation
|
Lawlor, C.
|
|
2010
|
|
23-24 |
p. 1107-
1 p.
|
artikel
|
| 22 |
Biosimilars and biobetters as tools for understanding and mitigating the immunogenicity of biotherapeutics
|
Barbosa, Maria D.F.S.
|
|
2012
|
|
23-24 |
p. 1282-1288
7 p.
|
artikel
|
| 23 |
Carbon nanotube-dendron series for siRNA delivery: mechanisms of cellular internalisation
|
Guo, Chang
|
|
2010
|
|
23-24 |
p. 1100-
1 p.
|
artikel
|
| 24 |
Cationic PLGA nanoparticles loaded with DNA for gene delivery delivery
|
Fay, Francois
|
|
2010
|
|
23-24 |
p. 1087-1088
2 p.
|
artikel
|
| 25 |
Cationic star homo- and co-polymers for gene delivery
|
Georgiou, Theoni K.
|
|
2010
|
|
23-24 |
p. 1104-
1 p.
|
artikel
|
| 26 |
CB1 receptor antagonism: biological basis for metabolic effects
|
Di Marzo, Vincenzo
|
|
2008
|
|
23-24 |
p. 1026-1041
16 p.
|
artikel
|
| 27 |
Cell-specific delivery of biologicals: problems, pitfalls and possibilities of antifibrotic compounds in the liver
|
Poelstra, Klaas
|
|
2013
|
|
23-24 |
p. 1237-1242
6 p.
|
artikel
|
| 28 |
Cellular delivery and biological activity of metall complex-peptide conjugates
|
Splith, Katrin
|
|
2010
|
|
23-24 |
p. 1096-1097
2 p.
|
artikel
|
| 29 |
Cellular delivery of oligonucleotides by PepFect
|
Padari, Kärt
|
|
2010
|
|
23-24 |
p. 1092-1093
2 p.
|
artikel
|
| 30 |
Cellular Delivery of Therapeutic Macromolecules (CDTM) International Symposium 2010: lessons and progress from inter-disciplinary science
|
Gumbleton, Mark
|
|
2010
|
|
23-24 |
p. 1079-1080
2 p.
|
artikel
|
| 31 |
Cellular internalisation of humanized IgG antibody changes by functionalization onto multi-walled carbon nanotubes
|
Guo, Chang
|
|
2010
|
|
23-24 |
p. 1100-1101
2 p.
|
artikel
|
| 32 |
Cellular uptake of long-circulating pH-sensitive liposomes: evaluation of the liposome and its encapsulated material penetration in cancer cells
|
Ducat, Emilie
|
|
2010
|
|
23-24 |
p. 1083-
1 p.
|
artikel
|
| 33 |
Central nervous system biomarkers for antiobesity drug development
|
Ziauddeen, Hisham
|
|
2013
|
|
23-24 |
p. 1282-1291
10 p.
|
artikel
|
| 34 |
Changes to Drug Discovery Today for 2006
|
Carney, Steve
|
|
2005
|
|
23-24 |
p. 1575-1576
2 p.
|
artikel
|
| 35 |
Characterisation of a cytosolic shuttle based upon ricin toxin
|
Richardson, S.C.W.
|
|
2010
|
|
23-24 |
p. 1108-
1 p.
|
artikel
|
| 36 |
Characterization of polymer-coated nanoparticles based on DNA condensation via spermine
|
Rata-Aguilar, A.
|
|
2010
|
|
23-24 |
p. 1105-1106
2 p.
|
artikel
|
| 37 |
Chemistry and integrated services in emerging countries
|
Agarwal, Ridhima
|
|
2012
|
|
23-24 |
p. 1251-1253
3 p.
|
artikel
|
| 38 |
Click chemistry for the generation of cell permeable apoptotic peptides
|
Fricke, Thomas
|
|
2010
|
|
23-24 |
p. 1088-
1 p.
|
artikel
|
| 39 |
Clinical prediction rules: new opportunities for pharma
|
Herscu, Paul
|
|
2009
|
|
23-24 |
p. 1143-1149
7 p.
|
artikel
|
| 40 |
Combating cardiovascular disease with angiogenic therapy
|
Jacobs, Jack
|
|
2007
|
|
23-24 |
p. 1040-1045
6 p.
|
artikel
|
| 41 |
Combination of a triblock copolymer L64 with electrotransfer increases gene delivery in vitro
|
Wasungu, Luc
|
|
2010
|
|
23-24 |
p. 1104-1105
2 p.
|
artikel
|
| 42 |
Combinatorial library methodology applied to cancer and protease targets
|
Edwards, Paul J.
|
|
2008
|
|
23-24 |
p. 1107-1108
2 p.
|
artikel
|
| 43 |
Competitive collaboration in the pharmaceutical and biotechnology industry
|
Bingham, Alph
|
|
2009
|
|
23-24 |
p. 1079-1081
3 p.
|
artikel
|
| 44 |
Computational analysis of membrane proteins: the largest class of drug targets
|
Arinaminpathy, Yalini
|
|
2009
|
|
23-24 |
p. 1130-1135
6 p.
|
artikel
|
| 45 |
Connecting the dots: role of standardization and technology sharing in biological simulation
|
Ghosh, Samik
|
|
2010
|
|
23-24 |
p. 1024-1031
8 p.
|
artikel
|
| 46 |
Contents
|
|
|
2009
|
|
23-24 |
p. iii-
1 p.
|
artikel
|
| 47 |
Contents
|
|
|
2009
|
|
23-24 |
p. i-
1 p.
|
artikel
|
| 48 |
Contents
|
|
|
2007
|
|
23-24 |
p. i-
1 p.
|
artikel
|
| 49 |
Contents
|
|
|
2011
|
|
23-24 |
p. i-
1 p.
|
artikel
|
| 50 |
Contents
|
|
|
2011
|
|
23-24 |
p. iii-
1 p.
|
artikel
|
| 51 |
Contents
|
|
|
2013
|
|
23-24 |
p. i-
1 p.
|
artikel
|
| 52 |
Contents
|
|
|
2013
|
|
23-24 |
p. iii-
1 p.
|
artikel
|
| 53 |
Contents
|
|
|
2013
|
|
23-24 |
p. ii-
1 p.
|
artikel
|
| 54 |
Contents page 1
|
|
|
2010
|
|
23-24 |
p. i-
1 p.
|
artikel
|
| 55 |
Contents page 1
|
|
|
2008
|
|
23-24 |
p. i-
1 p.
|
artikel
|
| 56 |
Contents page 2
|
|
|
2008
|
|
23-24 |
p. iii-
1 p.
|
artikel
|
| 57 |
Contents page 2
|
|
|
2010
|
|
23-24 |
p. iii-
1 p.
|
artikel
|
| 58 |
Contents page 2
|
|
|
2012
|
|
23-24 |
p. iii-
1 p.
|
artikel
|
| 59 |
Contents page 1
|
|
|
2012
|
|
23-24 |
p. i-
1 p.
|
artikel
|
| 60 |
Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs
|
van Rijt, Sabine H.
|
|
2009
|
|
23-24 |
p. 1089-1097
9 p.
|
artikel
|
| 61 |
Current challenges and opportunities in nonclinical safety testing of biologics
|
Kronenberg, Sven
|
|
2013
|
|
23-24 |
p. 1138-1143
6 p.
|
artikel
|
| 62 |
Cytosolic delivery of macromolecules using pH-dependent fusogenic peptide
|
Nakase, Ikuhiko
|
|
2010
|
|
23-24 |
p. 1095-
1 p.
|
artikel
|
| 63 |
Decision theory and the evaluation of risks and benefits of clinical trials
|
Bernabe, Rosemarie D.C.
|
|
2012
|
|
23-24 |
p. 1263-1269
7 p.
|
artikel
|
| 64 |
Delegate Abstracts
|
|
|
2010
|
|
23-24 |
p. 1080-1114
35 p.
|
artikel
|
| 65 |
Design and development of polymeric nanoparticles for targeted delivery of nucleic acid-based therapeutics to tumor sites
|
Le Breton, Aude
|
|
2010
|
|
23-24 |
p. 1080-
1 p.
|
artikel
|
| 66 |
Development of a high throughput method for screening of novel nanotechnologies for siRNA transfection of airway cells using high content screening (HCS)
|
Hibbitts, A.
|
|
2010
|
|
23-24 |
p. 1107-1108
2 p.
|
artikel
|
| 67 |
Development of a microwell device for correlative light and electron microscopy
|
Sayers, Edward
|
|
2010
|
|
23-24 |
p. 1101-
1 p.
|
artikel
|
| 68 |
Developments towards antiviral therapies against enterovirus 71
|
Wu, Kan X.
|
|
2010
|
|
23-24 |
p. 1041-1051
11 p.
|
artikel
|
| 69 |
Diary (December)
|
|
|
2006
|
|
23-24 |
p. 1124-
1 p.
|
artikel
|
| 70 |
Differential transport of anionic PAMAM dendrimers across in vitro biological barriers
|
Aljayyoussi, Ghaith
|
|
2010
|
|
23-24 |
p. 1114-
1 p.
|
artikel
|
| 71 |
Drug development in the light of translational science: shine or shade?
|
Wehling, Martin
|
|
2011
|
|
23-24 |
p. 1076-1083
8 p.
|
artikel
|
| 72 |
Drug dissolution: significance of physicochemical properties and physiological conditions
|
Jambhekar, Sunil S.
|
|
2013
|
|
23-24 |
p. 1173-1184
12 p.
|
artikel
|
| 73 |
Druggability of the enzymes of the non-mevalonate-pathway
|
Masini, Tiziana
|
|
2013
|
|
23-24 |
p. 1256-1262
7 p.
|
artikel
|
| 74 |
Druggability: selecting optimized drug candidates
|
Sugiyama, Yuichi
|
|
2005
|
|
23-24 |
p. 1577-1579
3 p.
|
artikel
|
| 75 |
Editorial Board
|
|
|
2007
|
|
23-24 |
p. iii-
1 p.
|
artikel
|
| 76 |
Efficient gene delivery using acid-responsive lipid envelopes for adenovirus
|
Van den Bossche, Jeroen
|
|
2010
|
|
23-24 |
p. 1089-
1 p.
|
artikel
|
| 77 |
Efficient siRNA delivery and effective gene silencing by lipoplexes
|
Metwally, Abdelkader A.
|
|
2010
|
|
23-24 |
p. 1090-
1 p.
|
artikel
|
| 78 |
Electrically based transdermal techniques for delivery of therapeutic macromolecules
|
Tiwari, Rakesh Kumar
|
|
2010
|
|
23-24 |
p. 1111-1112
2 p.
|
artikel
|
| 79 |
Endocytic DNA and siRNA delivery mediated by pH sensitive peptides
|
So, Mia S.W.
|
|
2010
|
|
23-24 |
p. 1086-
1 p.
|
artikel
|
| 80 |
Endosomal DNA release studies using giant unilamellar vesicles as model endosomal membranes
|
Kudsiova, Laila
|
|
2010
|
|
23-24 |
p. 1108-
1 p.
|
artikel
|
| 81 |
Engineering functional chitosan for delivery of drugs or RNAs
|
Liu, Xiudong
|
|
2010
|
|
23-24 |
p. 1084-1085
2 p.
|
artikel
|
| 82 |
Engineering macrophages to synthesize recombinant adenoviruses in hypoxic areas of human prostate tumours
|
Muthana, Munitta
|
|
2010
|
|
23-24 |
p. 1097-1098
2 p.
|
artikel
|
| 83 |
Enhanced intracellular delivery by guanidinium functionalized ROMP-polymers
|
Tezgel, A. Ozgul
|
|
2010
|
|
23-24 |
p. 1084-
1 p.
|
artikel
|
| 84 |
Epigenetic mechanisms in developmental programming of adult disease
|
Chen, Man
|
|
2011
|
|
23-24 |
p. 1007-1018
12 p.
|
artikel
|
| 85 |
Epigenetic therapies for non-oncology indications
|
Best, Jonathan D.
|
|
2010
|
|
23-24 |
p. 1008-1014
7 p.
|
artikel
|
| 86 |
Erratum
|
|
|
2005
|
|
23-24 |
p. 1695-
1 p.
|
artikel
|
| 87 |
Essential considerations for using protein–ligand structures in drug discovery
|
Warren, Gregory L.
|
|
2012
|
|
23-24 |
p. 1270-1281
12 p.
|
artikel
|
| 88 |
Essential properties of drug-targeting delivery systems
|
Petrak, Karel
|
|
2005
|
|
23-24 |
p. 1667-1673
7 p.
|
artikel
|
| 89 |
Exploiting a bacterial toxin translocation domain for the endosomal escape of CPP-imported cargoes
|
Mohammed, Arshiya F.
|
|
2010
|
|
23-24 |
p. 1094-
1 p.
|
artikel
|
| 90 |
Facilitating production of cell banks using an automated cryovial dispenser
|
Guy, Stephen
|
|
2011
|
|
23-24 |
p. 1093-
1 p.
|
artikel
|
| 91 |
Finding new drug targets in the 21st century
|
Lindsay, Mark A.
|
|
2005
|
|
23-24 |
p. 1683-1687
5 p.
|
artikel
|
| 92 |
Food for thought
|
Tulp, Martin
|
|
2006
|
|
23-24 |
p. 1115-1121
7 p.
|
artikel
|
| 93 |
Formulation of new reducible liposomes for gene delivery
|
Pezzoli, Daniele
|
|
2010
|
|
23-24 |
p. 1102-
1 p.
|
artikel
|
| 94 |
Four-wave mixing imaging to study protein entry and release in mammalian cells
|
Masia, Francesco
|
|
2010
|
|
23-24 |
p. 1089-
1 p.
|
artikel
|
| 95 |
Fragment-based hit identification: thinking in 3D
|
Morley, Andrew D.
|
|
2013
|
|
23-24 |
p. 1221-1227
7 p.
|
artikel
|
| 96 |
From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research
|
Cassels, Bruce K.
|
|
2005
|
|
23-24 |
p. 1657-1665
9 p.
|
artikel
|
| 97 |
From the ELRIG High Throughput BioProcess Development Meeting 22nd June 2011
|
|
|
2011
|
|
23-24 |
p. 1092-
1 p.
|
artikel
|
| 98 |
Gene electrotransfer: comparison between 2D cultured cells and multicellular tumor spheroid model
|
Chopinet, L.
|
|
2010
|
|
23-24 |
p. 1104-
1 p.
|
artikel
|
| 99 |
Generation and utility of genetically humanized mouse models
|
Scheer, Nico
|
|
2013
|
|
23-24 |
p. 1200-1211
12 p.
|
artikel
|
| 100 |
Genetic causes of cerebral folate deficiency: clinical, biochemical and therapeutic aspects
|
Serrano, Mercedes
|
|
2012
|
|
23-24 |
p. 1299-1306
8 p.
|
artikel
|
| 101 |
GPR119 agonists: a promising approach for T2DM treatment? A SWOT analysis of GPR119
|
Kang, Sang-Uk
|
|
2013
|
|
23-24 |
p. 1309-1315
7 p.
|
artikel
|
| 102 |
Heparin/heparan sulphate-based drugs
|
Gandhi, Neha S.
|
|
2010
|
|
23-24 |
p. 1058-1069
12 p.
|
artikel
|
| 103 |
High-efficient transfection using cationic lipids with programmed biodegradability
|
Unciti-Broceta, Asier
|
|
2010
|
|
23-24 |
p. 1111-
1 p.
|
artikel
|
| 104 |
High throughput analysis of N-glycans on microchip-CE platform
|
Bowes, Cathy
|
|
2011
|
|
23-24 |
p. 1093-
1 p.
|
artikel
|
| 105 |
High throughput microfluidic electrophoresis assays for rapid characterisation of low molecular weight protein therapeutic
|
Bowes, Cathy
|
|
2011
|
|
23-24 |
p. 1093-1094
2 p.
|
artikel
|
| 106 |
High-throughput process development technology for design of cleaning-in-place (CIP) protocols for chromatography media
|
Grönberg, Anna
|
|
2011
|
|
23-24 |
p. 1094-
1 p.
|
artikel
|
| 107 |
High throughput screening and optimization of intermediate wash conditions for a protein A chromatography step using a Design of Experiment (DoE) approach
|
Nilsson-Välimaa, Kristina
|
|
2011
|
|
23-24 |
p. 1094-
1 p.
|
artikel
|
| 108 |
High-throughput small scale bioreactors, Micro-24 Microbioreactors: a tool to develop the next generation of mammalian and microbial biopharmaceuticals and industrial biotechnology products
|
Rau, Tiffany D.
|
|
2011
|
|
23-24 |
p. 1092-
1 p.
|
artikel
|
| 109 |
Hope for Huntington's from an old antibiotic
|
Ashraf, Haroon
|
|
2005
|
|
23-24 |
p. 1582-1583
2 p.
|
artikel
|
| 110 |
HTS and hit finding in academia – from chemical genomics to drug discovery
|
Frearson, Julie A.
|
|
2009
|
|
23-24 |
p. 1150-1158
9 p.
|
artikel
|
| 111 |
Hybrid nanoparticles from cationic lipid and polyelectrolytes as antimicrobial agents
|
Melo, Letícia D.
|
|
2010
|
|
23-24 |
p. 1087-
1 p.
|
artikel
|
| 112 |
Imaging Alzheimer's disease pathology: one target, many ligands
|
Lockhart, Andrew
|
|
2006
|
|
23-24 |
p. 1093-1099
7 p.
|
artikel
|
| 113 |
Immune stimulation following microneedle delivery of influenza virus-like particle (VLP) vaccines to human skin
|
Pearton, Marc
|
|
2010
|
|
23-24 |
p. 1111-
1 p.
|
artikel
|
| 114 |
Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies
|
Liu, Yu-Hui
|
|
2013
|
|
23-24 |
p. 1212-1220
9 p.
|
artikel
|
| 115 |
Implementation of cell line development automation within the University of Manchester Centre of Excellence in Biopharmaceuticals
|
Lambert, Annes
|
|
2011
|
|
23-24 |
p. 1092-
1 p.
|
artikel
|
| 116 |
Incorporation of 2,3-diaminopropionic acid in linear cationic amphipathic peptides produces pH sensitive vectors
|
Lan, Yun
|
|
2010
|
|
23-24 |
p. 1085-
1 p.
|
artikel
|
| 117 |
Innovative automated small scale parallelized biochromatography for high throughput method development in downstream processing
|
Schroeder, Tim
|
|
2011
|
|
23-24 |
p. 1094-
1 p.
|
artikel
|
| 118 |
Innovators working hard to avoid patent exclusions in the US
|
Tombling, Adrian
|
|
2013
|
|
23-24 |
p. 1131-1132
2 p.
|
artikel
|
| 119 |
Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development
|
Agoram, Balaji M.
|
|
2011
|
|
23-24 |
p. 1031-1036
6 p.
|
artikel
|
| 120 |
Integration of fragment screening and library design
|
Siegal, Gregg
|
|
2007
|
|
23-24 |
p. 1032-1039
8 p.
|
artikel
|
| 121 |
Integration of models and experimentation to optimise the production of potential biotherapeutics
|
Royle, Kate E.
|
|
2013
|
|
23-24 |
p. 1250-1255
6 p.
|
artikel
|
| 122 |
Interdisciplinary research and education at the biology-engineering-computer science interface: a perspective (reprinted article)
|
Tadmor, Brigitta
|
|
2005
|
|
23-24 |
p. 1706-1712
7 p.
|
artikel
|
| 123 |
Interference of mycobacterium tuberculosis with the endocytic pathways on macrophages and dendritic cells from healthy donors: role of cathepsins
|
Pires, D.
|
|
2010
|
|
23-24 |
p. 1112-
1 p.
|
artikel
|
| 124 |
Intracellular iron oxide nanoparticle coating stability determines nanoparticle usability and cell functionality
|
Soenen, S.J.
|
|
2010
|
|
23-24 |
p. 1082-
1 p.
|
artikel
|
| 125 |
Investigating the effects of cationic lipid-mediated toxicity and how to optimize liposomal systems for transfection purposes
|
Soenen, S.J.
|
|
2010
|
|
23-24 |
p. 1081-1082
2 p.
|
artikel
|
| 126 |
Investigation of microsphere-mediated cellular delivery
|
Sanchez-Martın, R.M.
|
|
2010
|
|
23-24 |
p. 1094-
1 p.
|
artikel
|
| 127 |
In vitro silencing of TGFβ1 in a corneal epithelial cell line using nanoparticles
|
Arranz-Valsero, Isabel
|
|
2010
|
|
23-24 |
p. 1089-1090
2 p.
|
artikel
|
| 128 |
In vivo phage display to identify peptides that target the brain
|
Smith, Mathew W.
|
|
2010
|
|
23-24 |
p. 1113-
1 p.
|
artikel
|
| 129 |
Keynote review: Histamine H3 receptor antagonists reach out for the clinic
|
Celanire, Sylvain
|
|
2005
|
|
23-24 |
p. 1613-1627
15 p.
|
artikel
|
| 130 |
Kinases in cationic lipid/polymer-mediated gene delivery
|
Rehman, Zia ur
|
|
2010
|
|
23-24 |
p. 1110-
1 p.
|
artikel
|
| 131 |
Knowledge-based chemoinformatic approaches to drug discovery
|
Ghose, Arup K.
|
|
2006
|
|
23-24 |
p. 1107-1114
8 p.
|
artikel
|
| 132 |
Live-cell imaging and single-particle tracking of polyplex internalization
|
Ruthardt, Nadia
|
|
2010
|
|
23-24 |
p. 1093-
1 p.
|
artikel
|
| 133 |
Low-dose drug combinations along molecular pathways could maximize therapeutic effectiveness while minimizing collateral adverse effects
|
Lötsch, Jörn
|
|
2011
|
|
23-24 |
p. 1001-1006
6 p.
|
artikel
|
| 134 |
Lyotropic liquid crystal systems in drug delivery
|
Guo, Chenyu
|
|
2010
|
|
23-24 |
p. 1032-1040
9 p.
|
artikel
|
| 135 |
Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data
|
Muresan, Sorel
|
|
2011
|
|
23-24 |
p. 1019-1030
12 p.
|
artikel
|
| 136 |
Massive variability in a stable binding protein
|
Sutherland, Stephani
|
|
2005
|
|
23-24 |
p. 1580-
1 p.
|
artikel
|
| 137 |
Medicinal mushroom cuts off prostate cancer cells' blood supply
|
Johnston, Nicole
|
|
2005
|
|
23-24 |
p. 1584-
1 p.
|
artikel
|
| 138 |
Medicines for rare (orphan) diseases: an enquiry and proposal for tax-incentives
|
John, Jacob E.
|
|
2011
|
|
23-24 |
p. 999-1000
2 p.
|
artikel
|
| 139 |
Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives
|
Navarro, Maribel
|
|
2010
|
|
23-24 |
p. 1070-1078
9 p.
|
artikel
|
| 140 |
Microarrays, databases and hard, hard sums
|
Bousfield, David
|
|
2005
|
|
23-24 |
p. 1594-1597
4 p.
|
artikel
|
| 141 |
Microcalorimetric and spectroscopic studies on the mechanism of interaction between novel peptoids and lipid bilayers - effect of length, charge and N-terminal end group
|
Jing, Xiaona
|
|
2010
|
|
23-24 |
p. 1109-
1 p.
|
artikel
|
| 142 |
MicroRNAs: novel therapeutic targets in neurodegenerative diseases
|
Roshan, Reema
|
|
2009
|
|
23-24 |
p. 1123-1129
7 p.
|
artikel
|
| 143 |
Microsphere-mediated delivery of therapeutic peptides on neuronal cells
|
Pérez-López, Ana M.
|
|
2010
|
|
23-24 |
p. 1102-1103
2 p.
|
artikel
|
| 144 |
Models for open innovation in the pharmaceutical industry
|
Schuhmacher, Alexander
|
|
2013
|
|
23-24 |
p. 1133-1137
5 p.
|
artikel
|
| 145 |
Modern multiple sclerosis treatment – what is approved, what is on the horizon
|
Pilz, Georg
|
|
2008
|
|
23-24 |
p. 1013-1025
13 p.
|
artikel
|
| 146 |
Modulating GPR40: therapeutic promise and potential in diabetes
|
Poitout, Vincent
|
|
2013
|
|
23-24 |
p. 1301-1308
8 p.
|
artikel
|
| 147 |
Molecularly imprinted polymers: macromolecule recognition
|
Kelly, Marc
|
|
2010
|
|
23-24 |
p. 1112-
1 p.
|
artikel
|
| 148 |
Monitor – An inhibitor of insulin-like growth factor-1 receptor kinase with in vivo antitumour activity
|
Westwell, Andrew D.
|
|
2005
|
|
23-24 |
p. 1703-1704
2 p.
|
artikel
|
| 149 |
Monitor – chemistry
|
Westwell, Andrew D.
|
|
2005
|
|
23-24 |
p. 1703-
1 p.
|
artikel
|
| 150 |
Monitor – New TRPV1-targeting agents for pain management
|
González-Muñiz, Rosario
|
|
2005
|
|
23-24 |
p. 1704-1705
2 p.
|
artikel
|
| 151 |
More songs o' science
|
Rowe, Raymond C.
|
|
2005
|
|
23-24 |
p. 1611-1612
2 p.
|
artikel
|
| 152 |
mRNA delivery to cervical carcinoma and mesenchymal stem cells mediated by cationic carriers
|
Rejman, Joanna
|
|
2010
|
|
23-24 |
p. 1083-
1 p.
|
artikel
|
| 153 |
Multi-dimensional QSAR in drug discovery
|
Lill, Markus A.
|
|
2007
|
|
23-24 |
p. 1013-1017
5 p.
|
artikel
|
| 154 |
Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers
|
Dawar, Swati
|
|
2013
|
|
23-24 |
p. 1292-1300
9 p.
|
artikel
|
| 155 |
Multiple sclerosis poses tough drug development challenges
|
Senior, Kathryn
|
|
2005
|
|
23-24 |
p. 1583-1584
2 p.
|
artikel
|
| 156 |
Muscle-targeted HIF-1a gene expression system for therapeutic angiogenesis in ischemic limbs
|
Song, Hongmei
|
|
2010
|
|
23-24 |
p. 1091-1092
2 p.
|
artikel
|
| 157 |
Nanomedicine transforms drug delivery
|
Shaffer, Catherine
|
|
2005
|
|
23-24 |
p. 1581-1582
2 p.
|
artikel
|
| 158 |
Neuroprotection in traumatic brain injury
|
Jain, K.K.
|
|
2008
|
|
23-24 |
p. 1082-1089
8 p.
|
artikel
|
| 159 |
Neurotrophin delivery using nanotechnology
|
Angelova, Angelina
|
|
2013
|
|
23-24 |
p. 1263-1271
9 p.
|
artikel
|
| 160 |
New anti-tuberculosis drugs in clinical trials with novel mechanisms of action
|
Rivers, Emma C.
|
|
2008
|
|
23-24 |
p. 1090-1098
9 p.
|
artikel
|
| 161 |
New configuration of an in vitro blood–brain barrier model
|
Urich, Eduard
|
|
2010
|
|
23-24 |
p. 1109-1110
2 p.
|
artikel
|
| 162 |
New perspectives in pharmacological treatment of mild persistent asthma
|
Montuschi, Paolo
|
|
2011
|
|
23-24 |
p. 1084-1091
8 p.
|
artikel
|
| 163 |
New therapeutic approaches to treating hypertension in pregnancy
|
Mate, Alfonso
|
|
2012
|
|
23-24 |
p. 1307-1315
9 p.
|
artikel
|
| 164 |
Nonclinical development of biopharmaceuticals
|
Baumann, Andreas
|
|
2009
|
|
23-24 |
p. 1112-1122
11 p.
|
artikel
|
| 165 |
Non-optical screening platforms: the next wave in label-free screening?
|
Cooper, Matthew A.
|
|
2006
|
|
23-24 |
p. 1068-1074
7 p.
|
artikel
|
| 166 |
Non-toxic, highly efficient delivery of nucleic acids into challenging cells using safectin transfection reagent
|
Howell, Steve
|
|
2010
|
|
23-24 |
p. 1114-
1 p.
|
artikel
|
| 167 |
Novel and emerging therapies for asthma
|
Leath, Thomas M.
|
|
2005
|
|
23-24 |
p. 1647-1655
9 p.
|
artikel
|
| 168 |
Novel antitumour agents
|
Westwell, Andrew D.
|
|
2006
|
|
23-24 |
p. 1122-1123
2 p.
|
artikel
|
| 169 |
Novel compounds directed against the inhibition of protease cascades
|
Edwards, Paul
|
|
2007
|
|
23-24 |
p. 1083-1084
2 p.
|
artikel
|
| 170 |
Novel fluorescent proteins for high-content screening
|
Wolff, Michael
|
|
2006
|
|
23-24 |
p. 1054-1060
7 p.
|
artikel
|
| 171 |
Novel formulations for tuberculostatic drugs based on cationic lipid
|
Barbassa, Lilian
|
|
2010
|
|
23-24 |
p. 1087-
1 p.
|
artikel
|
| 172 |
Novel therapeutic strategies for treatment of visceral leishmaniasis
|
Jain, Keerti
|
|
2013
|
|
23-24 |
p. 1272-1281
10 p.
|
artikel
|
| 173 |
Nuclear inclusion of inert and chromatin-targeted polystyrene beads and plasmid DNA containing nanoparticles
|
Symens, N.
|
|
2010
|
|
23-24 |
p. 1082-1083
2 p.
|
artikel
|
| 174 |
Octaarginine mediated delivery of fluorescent cargo to human smooth muscle cells
|
Sweeney, Michele
|
|
2010
|
|
23-24 |
p. 1085-
1 p.
|
artikel
|
| 175 |
One target–multiple indications: a call for an integrated common mechanisms strategy
|
Nielsch, Ulrich
|
|
2007
|
|
23-24 |
p. 1025-1031
7 p.
|
artikel
|
| 176 |
Optical biosensors: where next and how soon?
|
Cooper, Matthew A.
|
|
2006
|
|
23-24 |
p. 1061-1067
7 p.
|
artikel
|
| 177 |
Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases
|
Pillarisetti, Sivaram
|
|
2009
|
|
23-24 |
p. 1098-1111
14 p.
|
artikel
|
| 178 |
Peptide-assisted traffic engineering for nonviral gene therapy
|
Vázquez, Esther
|
|
2008
|
|
23-24 |
p. 1067-1074
8 p.
|
artikel
|
| 179 |
Peptide-based nano-particle for in vivo delivery of siRNA
|
Rydstrom, A.
|
|
2010
|
|
23-24 |
p. 1110-1111
2 p.
|
artikel
|
| 180 |
Peptide dendrimer based drug delivery system
|
Luo, Kui
|
|
2010
|
|
23-24 |
p. 1090-1091
2 p.
|
artikel
|
| 181 |
Phage display as a technology delivering on the promise of peptide drug discovery
|
Hamzeh-Mivehroud, Maryam
|
|
2013
|
|
23-24 |
p. 1144-1157
14 p.
|
artikel
|
| 182 |
Phage display identification of a lung transduction peptide that affords enhanced macromolecule transport across the intact lung epithelium
|
Morris, Christopher J.
|
|
2010
|
|
23-24 |
p. 1113-1114
2 p.
|
artikel
|
| 183 |
Pharmaceutical R&D in the spotlight: why is there still unmet medical need?
|
Schmid, Esther F.
|
|
2007
|
|
23-24 |
p. 998-1006
9 p.
|
artikel
|
| 184 |
Pharmacogenetics of EGFR and VEGF inhibition
|
Pander, Jan
|
|
2007
|
|
23-24 |
p. 1054-1060
7 p.
|
artikel
|
| 185 |
Pharmacoproteomics: a chess game on a protein field
|
D’Alessandro, Angelo
|
|
2010
|
|
23-24 |
p. 1015-1023
9 p.
|
artikel
|
| 186 |
Physiological relevance of GPCR oligomerization and its impact on drug discovery
|
Panetta, Rosemarie
|
|
2008
|
|
23-24 |
p. 1059-1066
8 p.
|
artikel
|
| 187 |
Pivotal role of microRNAs in cardiac physiology and heart failure
|
Leite-Moreira, André M.
|
|
2013
|
|
23-24 |
p. 1243-1249
7 p.
|
artikel
|
| 188 |
Platforms for high-throughput screening of Wnt/Frizzled antagonists
|
Koval, Alexey
|
|
2012
|
|
23-24 |
p. 1316-1322
7 p.
|
artikel
|
| 189 |
Polyelectrolite complex based microspheres for colon specific anticancer drug delivery
|
Glavas Dodov, M.
|
|
2010
|
|
23-24 |
p. 1097-
1 p.
|
artikel
|
| 190 |
Polymer–drug conjugates: present state of play and future perspectives
|
Pang, Xin
|
|
2013
|
|
23-24 |
p. 1316-1322
7 p.
|
artikel
|
| 191 |
Potential drug interventions for diabetic retinopathy
|
Shen, Qin
|
|
2013
|
|
23-24 |
p. 1334-1341
8 p.
|
artikel
|
| 192 |
Practical proteomic biomarker discovery: taking a step back to leap forward
|
Listgarten, Jennifer
|
|
2005
|
|
23-24 |
p. 1697-1702
6 p.
|
artikel
|
| 193 |
Predicting protein druggability
|
Hajduk, Philip J.
|
|
2005
|
|
23-24 |
p. 1675-1682
8 p.
|
artikel
|
| 194 |
Preparation of solid DNA nanoparticles for use in gene therapy
|
Hanzlíková, Martina
|
|
2010
|
|
23-24 |
p. 1094-
1 p.
|
artikel
|
| 195 |
Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property
|
Mackey, Tim K.
|
|
2012
|
|
23-24 |
p. 1254-1257
4 p.
|
artikel
|
| 196 |
Protein delivery through the intestinal epithelium: a vitamin B12-mediated approach
|
Fowler, Robyn
|
|
2010
|
|
23-24 |
p. 1088-1089
2 p.
|
artikel
|
| 197 |
Proteomics studies reveal important information on small molecule therapeutics: a case study on plasma proteins
|
Zolla, Lello
|
|
2008
|
|
23-24 |
p. 1042-1051
10 p.
|
artikel
|
| 198 |
PubChem as a public resource for drug discovery
|
Li, Qingliang
|
|
2010
|
|
23-24 |
p. 1052-1057
6 p.
|
artikel
|
| 199 |
Pulmonary delivery of mRNA: in vitro and in vivo evaluation
|
Andries, Oliwia
|
|
2010
|
|
23-24 |
p. 1080-1081
2 p.
|
artikel
|
| 200 |
Pyridylhydrazone-based PEG for pH-reversible lipopolyplex shielding
|
Nie, Yu
|
|
2010
|
|
23-24 |
p. 1091-
1 p.
|
artikel
|
| 201 |
Quantifying uptake and distribution of arginine rich peptides at therapeutic concentrations using fluorescence correlation spectroscopy and image correlation spectroscopy techniques
|
Staley, Ben
|
|
2010
|
|
23-24 |
p. 1099-
1 p.
|
artikel
|
| 202 |
Rapid growth in Israel's life science industry
|
Barki, Therese
|
|
2005
|
|
23-24 |
p. 1591-1593
3 p.
|
artikel
|
| 203 |
Rational design of chemical genetic probes of RNA function and lead therapeutics targeting repeating transcripts
|
Disney, Matthew D.
|
|
2013
|
|
23-24 |
p. 1228-1236
9 p.
|
artikel
|
| 204 |
Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination
|
Hegde, Nagendra R.
|
|
2011
|
|
23-24 |
p. 1061-1068
8 p.
|
artikel
|
| 205 |
Recent developments in microwave-assisted protein chemistries – can this be integrated into the drug discovery and validation process?
|
Sandoval, Wendy N.
|
|
2008
|
|
23-24 |
p. 1075-1081
7 p.
|
artikel
|
| 206 |
Reconsidering the drug discovery pipeline for designed multitarget drugs
|
Proschak, Ewgenij
|
|
2013
|
|
23-24 |
p. 1129-1130
2 p.
|
artikel
|
| 207 |
Reduced transgene persistence and trafficking to nuclear periphery are barriers to transfection in lipid substituted nonviral cationic polymer
|
Hsu, Charlie
|
|
2010
|
|
23-24 |
p. 1106-
1 p.
|
artikel
|
| 208 |
Representativity of target families in the Protein Data Bank: impact for family-directed structure-based drug discovery
|
Mestres, Jordi
|
|
2005
|
|
23-24 |
p. 1629-1637
9 p.
|
artikel
|
| 209 |
Rethinking leadership in drug discovery projects
|
Schneider, Andreas
|
|
2012
|
|
23-24 |
p. 1258-1262
5 p.
|
artikel
|
| 210 |
Role of cell-surface carbohydrates and plasma membrane components in the internalization of cell-penetrating peptides
|
Bechara, Chérine
|
|
2010
|
|
23-24 |
p. 1101-
1 p.
|
artikel
|
| 211 |
Role of dynamin-dependent and clathrin-dependent uptake pathways in nonviral gene delivery studied by chemical and genetic means
|
Ilina, Polina
|
|
2010
|
|
23-24 |
p. 1084-
1 p.
|
artikel
|
| 212 |
Role of mycobacterium tuberculosis outer-membrane porins in bacterial survival within macrophages
|
Pires, D.
|
|
2010
|
|
23-24 |
p. 1112-1113
2 p.
|
artikel
|
| 213 |
Role of polymer architecture on polycation induced cell death: systematic study on molecular mechanism
|
Kadlecova, Zuzana
|
|
2010
|
|
23-24 |
p. 1086-
1 p.
|
artikel
|
| 214 |
SAINTargs, a novel lipid-based targeting device for siRNA delivery
|
Leus, Niek G.J.
|
|
2010
|
|
23-24 |
p. 1103-
1 p.
|
artikel
|
| 215 |
Saving big pharma from drowning in the data pool
|
Brown, Fiona
|
|
2006
|
|
23-24 |
p. 1043-1045
3 p.
|
artikel
|
| 216 |
Securing reliability and validity in biomedical research: an essential task
|
Wilckens, Thomas
|
|
2010
|
|
23-24 |
p. 991-996
6 p.
|
artikel
|
| 217 |
Significance of release technology in tissue engineering
|
Tabata, Yasuhiko
|
|
2005
|
|
23-24 |
p. 1639-1646
8 p.
|
artikel
|
| 218 |
Similarity-based virtual screening using 2D fingerprints
|
Willett, Peter
|
|
2006
|
|
23-24 |
p. 1046-1053
8 p.
|
artikel
|
| 219 |
siRNA containing nanoparticles: stability of encapsulation and particle size
|
Buyens, Kevin
|
|
2010
|
|
23-24 |
p. 1081-
1 p.
|
artikel
|
| 220 |
siRNA versus pharmacological inhibition of endocytic pathways for studying cellular uptake of cell penetrating peptides and other drug delivery vectors
|
Al-Soraj, Monerah H.
|
|
2010
|
|
23-24 |
p. 1103-
1 p.
|
artikel
|
| 221 |
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs
|
Vasconcelos, Teófilo
|
|
2007
|
|
23-24 |
p. 1068-1075
8 p.
|
artikel
|
| 222 |
Solid lipid nanoparticles for gene delivery into prostate cancer cells
|
de Jesus, Marcelo Bispo
|
|
2010
|
|
23-24 |
p. 1110-
1 p.
|
artikel
|
| 223 |
Sourcing natural killer cells for antitumor immunotherapy
|
Bradbury, Jane
|
|
2005
|
|
23-24 |
p. 1581-
1 p.
|
artikel
|
| 224 |
Status of terpenes as skin penetration enhancers
|
Aqil, Mohammed
|
|
2007
|
|
23-24 |
p. 1061-1067
7 p.
|
artikel
|
| 225 |
Steady state and dynamic control performance of the ambr™ automated micro bioreactor system in a CHO cell batch culture
|
Yau, Sinn Yee
|
|
2011
|
|
23-24 |
p. 1093-
1 p.
|
artikel
|
| 226 |
Storage and transmission of microarray images
|
Luo, Yu
|
|
2005
|
|
23-24 |
p. 1689-1695
7 p.
|
artikel
|
| 227 |
Strategies for microsphere-mediated delivery of oligonucleotides
|
Cardenas-Maestre, J.M.
|
|
2010
|
|
23-24 |
p. 1102-
1 p.
|
artikel
|
| 228 |
Structural mass spectrometry in biologics discovery: advances and future trends
|
Mo, Jingjie
|
|
2012
|
|
23-24 |
p. 1323-1330
8 p.
|
artikel
|
| 229 |
Studies towards improved cell-penetrating peptide-promoted macromolecular drug delivery
|
Clausen, Jacob A.D.
|
|
2010
|
|
23-24 |
p. 1109-
1 p.
|
artikel
|
| 230 |
Surrogate approaches in development of monoclonal antibodies
|
Bornstein, Gadi Gazit
|
|
2009
|
|
23-24 |
p. 1159-1165
7 p.
|
artikel
|
| 231 |
Systems biology, metabolic modelling and metabolomics in drug discovery and development
|
Kell, Douglas B.
|
|
2006
|
|
23-24 |
p. 1085-1092
8 p.
|
artikel
|
| 232 |
Targeted nanodrug delivery systems for the treatment of tuberculosis
|
Lemmer, Yolandy
|
|
2010
|
|
23-24 |
p. 1098-
1 p.
|
artikel
|
| 233 |
Targeted SAINT-O-Somes, a novel type of liposomes for improved delivery of siRNA
|
Kowalski, Piotr S.
|
|
2010
|
|
23-24 |
p. 1098-1099
2 p.
|
artikel
|
| 234 |
Targeting inflammation-induced transcription factor activation: an open frontier for glioma therapy
|
Sen, Ellora
|
|
2011
|
|
23-24 |
p. 1044-1051
8 p.
|
artikel
|
| 235 |
Tat-LK15, a Tat-fusion peptide, to deliver therapeutic siRNA in chronic myeloid leukemic cells
|
Arthanari, Yamini
|
|
2010
|
|
23-24 |
p. 1099-1100
2 p.
|
artikel
|
| 236 |
The druggable genome: an update
|
Russ, Andreas P.
|
|
2005
|
|
23-24 |
p. 1607-1610
4 p.
|
artikel
|
| 237 |
The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform
|
Shukla, Sunita J.
|
|
2010
|
|
23-24 |
p. 997-1007
11 p.
|
artikel
|
| 238 |
The highly permeable blood–brain barrier: an evaluation of current opinions about brain uptake capacity
|
Fagerholm, Urban
|
|
2007
|
|
23-24 |
p. 1076-1082
7 p.
|
artikel
|
| 239 |
The impact of accelerator processors for high-throughput molecular modeling and simulation
|
Giupponi, G.
|
|
2008
|
|
23-24 |
p. 1052-1058
7 p.
|
artikel
|
| 240 |
The MPTP marmoset model of Parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases
|
Philippens, Ingrid H.C.H.M.
|
|
2010
|
|
23-24 |
p. 985-990
6 p.
|
artikel
|
| 241 |
Therapeutic potential of interfering with apelin signalling
|
Sorli, S. Caroline
|
|
2006
|
|
23-24 |
p. 1100-1106
7 p.
|
artikel
|
| 242 |
Therapies for rheumatoid arthritis: hope springs eternal
|
Smith, Robert J.
|
|
2005
|
|
23-24 |
p. 1598-1606
9 p.
|
artikel
|
| 243 |
The role of mechanism-based pharmacokinetic–pharmacodynamic (PK–PD) modelling in translational research of biologics
|
Agoram, Balaji M.
|
|
2007
|
|
23-24 |
p. 1018-1024
7 p.
|
artikel
|
| 244 |
The role of the informatics framework in early lead discovery
|
Fay, Nicolas
|
|
2006
|
|
23-24 |
p. 1075-1084
10 p.
|
artikel
|
| 245 |
The targeted delivery of cancer drugs across the blood–brain barrier: chemical modifications of drugs or drug-nanoparticles?
|
Juillerat-Jeanneret, Lucienne
|
|
2008
|
|
23-24 |
p. 1099-1106
8 p.
|
artikel
|
| 246 |
The 5th generation of poly(l-lysine) dendrimer is a potential carrier for in vivo in gene delivery
|
Wang, Gang
|
|
2010
|
|
23-24 |
p. 1091-
1 p.
|
artikel
|
| 247 |
The TNF superfamily in 2009: new pathways, new indications, and new drugs
|
Tansey, Malú G.
|
|
2009
|
|
23-24 |
p. 1082-1088
7 p.
|
artikel
|
| 248 |
Toxin assisted intracellular delivery of gold nanoparticles
|
Shaheen, Umbreen
|
|
2010
|
|
23-24 |
p. 1099-
1 p.
|
artikel
|
| 249 |
Translation of rare disease research into orphan drug development: disease matters
|
Heemstra, Harald E.
|
|
2009
|
|
23-24 |
p. 1166-1173
8 p.
|
artikel
|
| 250 |
Unfinished business: target-based drug discovery
|
Brown, David
|
|
2007
|
|
23-24 |
p. 1007-1012
6 p.
|
artikel
|
| 251 |
Utilising the fluorescent properties of Laurdan to study plasma membrane fluidity in cells treated with the cell penetrating peptide R8
|
Watkins, Catherine
|
|
2010
|
|
23-24 |
p. 1106-
1 p.
|
artikel
|
| 252 |
Vascular endothelium remodeling in human African trypanosomiasis
|
Sanderson, L.
|
|
2010
|
|
23-24 |
p. 1093-
1 p.
|
artikel
|
| 253 |
Visualizing the effect of integrin targeting and surface shielding on gene vector uptake by live cell imaging
|
Koenig, F.M.
|
|
2010
|
|
23-24 |
p. 1095-1096
2 p.
|
artikel
|
| 254 |
What makes a good drug target?
|
Gashaw, Isabella
|
|
2011
|
|
23-24 |
p. 1037-1043
7 p.
|
artikel
|
Tijdschrift beschrijving